Autologous adipose-derived stem cell therapy【Nakara Clinic】

Regenerative Medicine NAKARA CLINIC(Kinki/Osaka)

Regenerative medicine restores your natural youthfulness
96% survival rate of live stem cell therapy
     

We also offer a dedicated concierge service for F0. We provide support from the first contact to your arrival in Japan, transportation from Kansai Airport to your hotel and clinic, interpretation, and follow-up after your return until your next visit to Japan.

Genres
  • Department
    Regenerative Medicine
  • Disease
    others Stem Cell Therapy
  • Examination Items/Treatments/Surgical method
    autologous adipose-derived stem cell therapy
  • Region/Organ
Program Summary
Chronic Pain
Osteoarthritis
Arthritis
AGA (Androgenetic Alopecia)
Myocardial Infarction, Angina Pectoris
Arteriosclerosis
Diabetes Mellitus
Chronic Kidney Disease, Liver Disease (Hepatitis, Cirrhosis, Liver Dysfunction, etc.)
Autoimmune Diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus, etc.)
Erectile Dysfunction
Anti-Aging Medicine (Rejuvenation of Skin, Blood Vessels, etc.)
Target diseases
Cerebral infarction
Spinal cord injury
Multiple sclerosis
Parkinson's disease
Alzheimer's type dementia
ALS (Amyotrophic lateral sclerosis)
Peripheral nerve disorder

Characteristics of the procedure: A small amount of adipose tissue is taken from subcutaneous fat, and the wound is hardly noticeable.
The fat extraction time will be completed in 30 to 60 minutes.
Medical Institutions
NAKARA CLINIC
〒542-0081
ACN Shinsaibashi Building 4F, 4-12-10 Minamisenba, Chuo-ku, Osaka
Examination Items
Setup Date
Excluded days
Required Days/Hours
Start/end time
Eligibility Criteria/Exclusions for Treatment
Patients diagnosed with neuropathic pain or nociceptive pain
・Age: 18 years old and above
・Treatment period: Stem cells are administered 6 weeks after fat collection (about 1 hour)
Precautions / Contraindications
・Those who have experienced hypersensitivity or allergic symptoms to anesthetics used in fat collection or substances used in the manufacturing process of specific cell processed products.
・Those who are positive for infectious diseases (HBs antigen, HCV antigen/antibody, HIV antigen/antibody, HTLV-1 antigen/antibody, syphilis)
・In addition, the doctor receiving this treatment will decide whether or not to provide the treatment in consideration of the health condition and physical condition of the person receiving the treatment.

Accommodation support companies in the same area